Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

Primary resistant Hodgkin lymphoma is an aggressive disease with few treatment options and short survival. Neoplastic cells of classical Hodgkin lymphoma are heavily dependent on microenvironmental stimuli, regularly express PD-L1, and a relevant proportion of relapsed patients is sensitive to block...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Greil, Richard, Pleyer, Lisa, Jansko, Bettina, Feierabend, Carmen, Rettenbacher, Lukas, Stiefel, Olga, Rass, Christoph, Morre, Patrick, Neureiter, Daniel, Greil-Ressler, Sigrun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2018
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5945535/
https://ncbi.nlm.nih.gov/pubmed/29755699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25037
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi